• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用多种分析方法证明体内 PEG 化蛋白的代谢裂解。

Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologies.

机构信息

MRC Centre for Drug Safety Science, Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, United Kingdom.

出版信息

Mol Pharm. 2012 May 7;9(5):1291-301. doi: 10.1021/mp200587m. Epub 2012 Apr 18.

DOI:10.1021/mp200587m
PMID:22480236
Abstract

PEGylation of therapeutic proteins is commonly used to extend half-lives and to reduce immunogenicity. However, reports of antibodies toward PEGylated proteins and of poly(ethylene glycol) (PEG) accumulation suggest that efficacy and safety concerns may arise. To understand the relationship among the pharmacology, immunogenicity, and toxicology of PEGylated proteins, we require knowledge of the disposition and metabolic fate of both the drug and the polymer moieties. The analysis of PEG by standard spectrophotometric or mass spectrometric techniques is problematic. Consequently, we have examined and compared two independent analytical approaches, based on gel electrophoresis and nuclear magnetic resonance (NMR) spectroscopy, to determine the biological fate of a model PEGylated protein, (40K)PEG-insulin, within a rat model. Both immunoblotting with an antibody to PEG and NMR analyses (LOD 0.5 μg/mL for both assays) indicated that the PEG moiety remained detectable for several weeks in both serum and urine following intravenous administration of (40K)PEG-insulin (4 mg/kg). In contrast, Western blotting with anti-insulin IgG indicated that the terminal half-life of the insulin moiety was far shorter than that of the PEG, providing clear evidence of conjugate cleavage. The application of combined analytical techniques in this way thus allows simultaneous independent monitoring of both protein and polymer elements of a PEGylated molecule. These methodologies also provide direct evidence for cleavage and definition of the chemical species present in biological fluids which may have toxicological consequences due to unconjugated PEG accumulation or immunogenic recognition of the uncoupled protein.

摘要

聚乙二醇(PEG)化治疗性蛋白通常用于延长半衰期和降低免疫原性。然而,关于针对聚乙二醇化蛋白的抗体和聚乙二醇(PEG)蓄积的报道表明,可能会出现疗效和安全性问题。为了了解聚乙二醇化蛋白的药理学、免疫原性和毒理学之间的关系,我们需要了解药物和聚合物部分的处置和代谢命运。使用标准分光光度法或质谱法分析 PEG 存在问题。因此,我们检查并比较了两种独立的分析方法,基于凝胶电泳和核磁共振(NMR)光谱,以确定模型聚乙二醇化蛋白(40K)PEG-胰岛素在大鼠模型中的生物学命运。用针对 PEG 的抗体进行免疫印迹和 NMR 分析(两种测定的检测限均为 0.5 μg/mL)均表明,在静脉内给予(40K)PEG-胰岛素(4 mg/kg)后,PEG 部分在血清和尿液中可检测数周。相比之下,用抗胰岛素 IgG 的 Western blot 分析表明,胰岛素部分的半衰期远短于 PEG,这提供了明显的缀合物断裂的证据。以这种方式应用组合分析技术可以同时独立监测聚乙二醇化分子的蛋白质和聚合物部分。这些方法还为生物流体中存在的化学物质的断裂和定义提供了直接证据,由于未结合的 PEG 蓄积或未偶联的蛋白质的免疫识别,这些化学物质可能具有毒理学后果。

相似文献

1
Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologies.利用多种分析方法证明体内 PEG 化蛋白的代谢裂解。
Mol Pharm. 2012 May 7;9(5):1291-301. doi: 10.1021/mp200587m. Epub 2012 Apr 18.
2
Magnetic Resonance and Ultrastructural Characterization of PEGylation-associated Vacuolation in Nonclinical Models.非临床模型中聚乙二醇化相关空泡化的磁共振和超微结构特征
Toxicol Pathol. 2017 Jul;45(5):604-613. doi: 10.1177/0192623317714068. Epub 2017 Jul 4.
3
Purification of pegylated proteins.聚乙二醇化蛋白质的纯化。
Methods Biochem Anal. 2011;54:339-62. doi: 10.1002/9780470939932.ch14.
4
[Induction of Anti-PEG Immune Responses by PEGylation of Proteins].[蛋白质聚乙二醇化诱导抗聚乙二醇免疫反应]
Yakugaku Zasshi. 2020;140(2):163-169. doi: 10.1248/yakushi.19-00187-5.
5
Quantitative analysis of polyethylene glycol (PEG) and PEGylated proteins in animal tissues by LC-MS/MS coupled with in-source CID.通过液相色谱-串联质谱联用(LC-MS/MS)结合源内碰撞诱导解离(CID)对动物组织中的聚乙二醇(PEG)和聚乙二醇化蛋白质进行定量分析。
Anal Chem. 2014 Aug 5;86(15):7642-9. doi: 10.1021/ac501507g. Epub 2014 Jul 8.
6
Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives.治疗诱导和预先存在的抗聚乙二醇抗体:流行率、临床意义和未来展望。
J Pharm Sci. 2024 Mar;113(3):555-578. doi: 10.1016/j.xphs.2023.11.001. Epub 2023 Nov 4.
7
Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.与40 kDa支链聚乙二醇共轭的乳铁蛋白具有更长的循环半衰期。
Pharm Res. 2009 Sep;26(9):2125-32. doi: 10.1007/s11095-009-9925-z. Epub 2009 Jun 25.
8
Sensitivity of PEGylated interferon detection by anti-polyethylene glycol (PEG) antibodies depends on PEG length.聚乙二醇(PEG)抗体检测 PEG 干扰素的敏感性取决于 PEG 的长度。
Bioconjug Chem. 2013 Aug 21;24(8):1408-13. doi: 10.1021/bc3006144.
9
PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.聚乙二醇化干扰素-α2b:一种分支状40K聚乙二醇衍生物。
Pharm Res. 2005 Aug;22(8):1374-86. doi: 10.1007/s11095-005-5278-4. Epub 2005 Aug 3.
10
PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats.聚乙二醇化乳铁蛋白增强了其对四氯化碳诱导的大鼠急性肝损伤的肝保护作用。
Food Chem Toxicol. 2009 Jul;47(7):1453-8. doi: 10.1016/j.fct.2009.03.030. Epub 2009 Mar 31.

引用本文的文献

1
MRI detection of free-contrast agent nanoparticles.MRI 检测游离对比剂纳米颗粒。
Magn Reson Med. 2025 Feb;93(2):761-774. doi: 10.1002/mrm.30292. Epub 2024 Sep 29.
2
Biological fate and interaction with cytochromes P450 of the nanocarrier material, d--tocopheryl polyethylene glycol 1000 succinate.纳米载体材料d-α-生育酚聚乙二醇1000琥珀酸酯的生物学命运及其与细胞色素P450的相互作用。
Acta Pharm Sin B. 2022 Jul;12(7):3156-3166. doi: 10.1016/j.apsb.2022.01.014. Epub 2022 Jan 25.
3
Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.
用于磷脂酰丝氨酸相关治疗应用的长循环 XTEN864-annexin A5 融合蛋白。
Apoptosis. 2021 Oct;26(9-10):534-547. doi: 10.1007/s10495-021-01686-w. Epub 2021 Aug 17.
4
Enhanced inhibition of influenza virus infection by peptide-noble-metal nanoparticle conjugates.肽-贵金属纳米颗粒共轭物对流感病毒感染的增强抑制作用。
Beilstein J Nanotechnol. 2019 May 14;10:1038-1047. doi: 10.3762/bjnano.10.104. eCollection 2019.
5
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.影响治疗性蛋白质ADME特性的关键因素:药物发现与开发中对ADME特性表征的需求。
MAbs. 2016;8(2):229-45. doi: 10.1080/19420862.2015.1115937. Epub 2015 Dec 4.
6
Recent developments in protein and peptide parenteral delivery approaches.蛋白质和肽类肠胃外给药方法的最新进展。
Ther Deliv. 2014 Mar;5(3):337-65. doi: 10.4155/tde.14.5.